Tag: Medication discontinuation

Statistics show that as many as 40% of people who stop taking antipsychotics may experience discontinuation syndrome. This emphasizes the critical importance of understanding what happens if antipsychotics are stopped abruptly, and why a safe, supervised tapering process is always necessary.

According to the Child Mind Institute, abruptly stopping certain ADHD medications can cause uncomfortable withdrawal symptoms and disrupt your daily functioning. Therefore, many people wonder, "**do you have to wean off ADHD medication**?" The answer is yes, depending on the specific medication, dosage, and duration of use, and this process should always be supervised by a healthcare provider.

Manufacturer Allergan discontinued Lumigan (bimatoprost ophthalmic solution) 0.03% in 2012, replacing it with a 0.01% formulation that provided comparable efficacy and a better safety profile. The change aimed to offer patients a more tolerable treatment option, not due to safety concerns with the original formulation.

In a study of 251 myelofibrosis patients who discontinued Jakafi (ruxolitinib), 13.5% experienced a discontinuation syndrome [1.2.1]. Understanding what happens when you stop taking Jakafi is critical for patient safety and managing disease symptoms.

Medical experts strongly advise against abruptly stopping antipsychotic medications like ziprasidone (Geodon), as this can trigger severe discontinuation syndrome and increase the risk of relapse. The short answer to the question, **does ziprasidone need to be tapered**?, is a definitive yes; a slow, medically-supervised reduction is the standard of care to ensure a safe outcome.

Nearly half of women treated with aromatase inhibitors like anastrozole report debilitating joint pain, a side effect that often leads to discontinuation [1.8.3]. So, what happens to your body when you stop taking anastrozole, either after completing treatment or prematurely?

According to studies, symptoms of tardive dyskinesia can return within four weeks of discontinuing Ingrezza, while chorea symptoms associated with Huntington's disease can return within two weeks. Therefore, understanding **what happens if I stop taking Ingrezza** and the risks of doing so is crucial for anyone on this medication.

An estimated 16.4 million adults in the U.S. have been diagnosed with Dry Eye Disease (DED) [1.9.2]. For many using prescription treatments, a common question arises: **Can you ever stop using Xiidra?** This article explores the answer.

First approved by the FDA in 2006, branded Atripla was discontinued by its manufacturer, Gilead Sciences, toward the end of 2021. The decision to remove the branded medication from the market was driven primarily by commercial factors and diminishing demand, not by concerns over its effectiveness or a sudden discovery of new safety issues.

The discontinuation of fluphenazine decanoate (Modecate) around 2018 was primarily due to manufacturing difficulties and unpredictable supplies of its active pharmaceutical ingredient [1.2.2, 1.4.3]. This article delves into why was fluphenazine discontinued and the impact on patients.